dd01
Peptideexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 24, 2021 (NCT04812262)
Timeline
Indications
Mechanism of action
- Glucagon receptorAGONIST
GCGR agonist
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06410924 | Phase 2 | Jun 13, 2024 | Neuraly, Inc |
| NCT04812262 | Phase 1 | Feb 24, 2021 | Neuraly, Inc |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Neuraly, Inc | For profit | 2 | 2 | 2 | 2021 |
1 organizations
Page 1 / 1